JP2017510296A5 - - Google Patents

Info

Publication number

JP2017510296A5

JP2017510296A5 JP2017501086A JP2017501086A JP2017510296A5 JP 2017510296 A5 JP2017510296 A5 JP 2017510296A5 JP 2017501086 A JP2017501086 A JP 2017501086A JP 2017501086 A JP2017501086 A JP 2017501086A JP 2017510296 A5 JP2017510296 A5 JP 2017510296A5

Authority

JP

Japan

Prior art keywords

seq

sequence

item

polynucleotide

polynucleotide cassette

Prior art date

2015-03-17

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Granted

Links

• Espacenet
• Global Dossier
• Discuss

• 108091033319 polynucleotide Proteins 0.000 claims description 70
• 102000040430 polynucleotide Human genes 0.000 claims description 70
• 239000002157 polynucleotide Substances 0.000 claims description 70
• 108091026890 Coding region Proteins 0.000 claims description 30
• 230000004456 color vision Effects 0.000 claims description 24
• 108700039691 Genetic Promoter Regions Proteins 0.000 claims description 23
• 210000004027 cell Anatomy 0.000 claims description 21
• 241000124008 Mammalia Species 0.000 claims description 19
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 17
• 208000002780 macular degeneration Diseases 0.000 claims description 14
• 210000002763 pyramidal cell Anatomy 0.000 claims description 14
• 108700026244 Open Reading Frames Proteins 0.000 claims description 12
• 108700019146 Transgenes Proteins 0.000 claims description 12
• 208000035475 disorder Diseases 0.000 claims description 11
• 108090000623 proteins and genes Proteins 0.000 claims description 11
• 208000035719 Maculopathy Diseases 0.000 claims description 10
• 230000004393 visual impairment Effects 0.000 claims description 9
• 239000012634 fragment Substances 0.000 claims description 8
• 206010047571 Visual impairment Diseases 0.000 claims description 7
• 230000001225 therapeutic effect Effects 0.000 claims description 7
• 208000029257 vision disease Diseases 0.000 claims description 7
• 241000702421 Dependoparvovirus Species 0.000 claims description 6
• 108091023045 Untranslated Region Proteins 0.000 claims description 6
• 230000014621 translational initiation Effects 0.000 claims description 6
• 108700028146 Genetic Enhancer Elements Proteins 0.000 claims description 5
• 102220474405 Long-wave-sensitive opsin 1_I111V_mutation Human genes 0.000 claims description 5
• 102220467647 Long-wave-sensitive opsin 1_I274V_mutation Human genes 0.000 claims description 5
• 102220467749 Long-wave-sensitive opsin 1_S116Y_mutation Human genes 0.000 claims description 5
• 102220512669 Olfactory receptor 51A7_Y277F_mutation Human genes 0.000 claims description 5
• 108700009124 Transcription Initiation Site Proteins 0.000 claims description 5
• 102220344502 c.853A>G Human genes 0.000 claims description 5
• 201000006754 cone-rod dystrophy Diseases 0.000 claims description 5
• 239000002773 nucleotide Substances 0.000 claims description 5
• 125000003729 nucleotide group Chemical group 0.000 claims description 5
• 102220212468 rs145009674 Human genes 0.000 claims description 5
• 102220187193 rs145041032 Human genes 0.000 claims description 5
• 102220050340 rs193920890 Human genes 0.000 claims description 5
• 102220030661 rs367601527 Human genes 0.000 claims description 5
• 102220044497 rs587781345 Human genes 0.000 claims description 5
• 102200117832 rs61754966 Human genes 0.000 claims description 5
• 206010007747 Cataract congenital Diseases 0.000 claims description 4
• 230000007850 degeneration Effects 0.000 claims description 4
• 239000008194 pharmaceutical composition Substances 0.000 claims description 4
• 230000008488 polyadenylation Effects 0.000 claims description 4
• 210000001525 retina Anatomy 0.000 claims description 4
• 102220323537 rs1555165268 Human genes 0.000 claims description 4
• 102200056668 rs76863441 Human genes 0.000 claims description 4
• 102220085731 rs771364038 Human genes 0.000 claims description 4
• 206010012689 Diabetic retinopathy Diseases 0.000 claims description 3
• 208000010412 Glaucoma Diseases 0.000 claims description 3
• 108091026898 Leader sequence (mRNA) Proteins 0.000 claims description 3
• 208000007014 Retinitis pigmentosa Diseases 0.000 claims description 3
• 206010043189 Telangiectasia Diseases 0.000 claims description 3
• 206010064930 age-related macular degeneration Diseases 0.000 claims description 3
• 230000002265 prevention Effects 0.000 claims description 3
• 208000004644 retinal vein occlusion Diseases 0.000 claims description 3
• 102220317277 rs1318754770 Human genes 0.000 claims description 3
• 208000009056 telangiectasis Diseases 0.000 claims description 3
• 108090000565 Capsid Proteins Proteins 0.000 claims description 2
• 102100023321 Ceruloplasmin Human genes 0.000 claims description 2
• 208000006992 Color Vision Defects Diseases 0.000 claims description 2
• 102220467646 Long-wave-sensitive opsin 1_I230T_mutation Human genes 0.000 claims description 2
• 201000007254 color blindness Diseases 0.000 claims description 2
• 239000000203 mixture Substances 0.000 claims description 2
• 230000002207 retinal effect Effects 0.000 claims description 2
• 230000009919 sequestration Effects 0.000 claims description 2
• 108020003589 5' Untranslated Regions Proteins 0.000 claims 2
• 208000037663 Best vitelliform macular dystrophy Diseases 0.000 claims 1
• 102000010175 Opsin Human genes 0.000 claims 1
• 201000007790 vitelliform macular dystrophy Diseases 0.000 claims 1
• 208000020938 vitelliform macular dystrophy 2 Diseases 0.000 claims 1
• 238000000034 method Methods 0.000 description 32
• 238000001415 gene therapy Methods 0.000 description 8
• 201000010099 disease Diseases 0.000 description 6
• 238000001476 gene delivery Methods 0.000 description 6
• 102220607407 SLAM family member 6_Y309F_mutation Human genes 0.000 description 5
• 210000000964 retinal cone photoreceptor cell Anatomy 0.000 description 5
• 208000024891 symptom Diseases 0.000 description 5
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 4
• 239000003814 drug Substances 0.000 description 4
• 102000004169 proteins and genes Human genes 0.000 description 4
• 229940124597 therapeutic agent Drugs 0.000 description 4
• 201000004569 Blindness Diseases 0.000 description 3
• 241000288906 Primates Species 0.000 description 3
• 208000034461 Progressive cone dystrophy Diseases 0.000 description 3
• 201000008615 cone dystrophy Diseases 0.000 description 3
• 229920001184 polypeptide Polymers 0.000 description 3
• 102000004196 processed proteins & peptides Human genes 0.000 description 3
• 108090000765 processed proteins & peptides Proteins 0.000 description 3
• 208000036443 AIPL1-related retinopathy Diseases 0.000 description 2
• 108091092195 Intron Proteins 0.000 description 2
• 208000009415 Spinocerebellar Ataxias Diseases 0.000 description 2
• 230000006735 deficit Effects 0.000 description 2
• 238000001727 in vivo Methods 0.000 description 2
• 201000003632 spinocerebellar ataxia type 7 Diseases 0.000 description 2
• 208000011580 syndromic disease Diseases 0.000 description 2
• 238000011144 upstream manufacturing Methods 0.000 description 2
• 208000036693 Color-vision disease Diseases 0.000 description 1
• 201000007737 Retinal degeneration Diseases 0.000 description 1
• 208000027073 Stargardt disease Diseases 0.000 description 1
• 230000004438 eyesight Effects 0.000 description 1
• 238000009472 formulation Methods 0.000 description 1
• 208000037805 labour Diseases 0.000 description 1
• 208000018769 loss of vision Diseases 0.000 description 1
• 231100000864 loss of vision Toxicity 0.000 description 1
• 239000002245 particle Substances 0.000 description 1
• 239000000546 pharmaceutical excipient Substances 0.000 description 1
• 229940124531 pharmaceutical excipient Drugs 0.000 description 1
• 108091008695 photoreceptors Proteins 0.000 description 1
• 201000007714 retinoschisis Diseases 0.000 description 1
• 102220057163 rs730880848 Human genes 0.000 description 1
• 230000000087 stabilizing effect Effects 0.000 description 1
• 238000002560 therapeutic procedure Methods 0.000 description 1
• 230000003612 virological effect Effects 0.000 description 1
• 230000000007 visual effect Effects 0.000 description 1